Commission Implementing Regulation (EU) 2026/356 of 18 February 2026 concerning the authorisation of a preparation of endo-1,4-beta-xylanase produced with Bacillus subtilis LMG S-15136 as a feed additive for gestating sows (holder of authorisation: Puratos NV)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Joint committee decision (JCD)
162/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2026/356 of 18 February 2026 concerning the authorisation of a preparation of endo-1,4-beta-xylanase produced with Bacillus subtilis LMG S-15136 as a feed additive for gestating sows (holder of authorisation: Puratos NV)
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2026/356 frá 18. febrúar 2026 um leyfi fyrir blöndu með endó-1,4-betaxýlanasa, sem er framleiddur með Bacillus subtilis LMG S-15136, sem fóðuraukefni fyrir gyltur á meðgöngu (leyfishafi er Puratos NV)
Durchführungsverordnung (EU) 2026/356 der Kommission vom 18. Februar 2026 zur Zulassung einer Zubereitung aus Endo-1,4-beta-Xylanase, hergestellt mit Bacillus subtilis LMG S-15136, als Zusatzstoff in Futtermitteln für trächtige Sauen (Zulassungsinhaber: Puratos NV)
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.